Cambridge in Davos
20 January 2014A delegation of Cambridge academics, led by the Vice-Chancellor, Professor Sir Leszek Borysiewicz, is attending the World Economic Forum’s Annual Meeting in Davos, Switzerland, this week.
Modafinil, a drug typically used to treat sleep disorders, reduces depression’s severity when taken with antidepressants
27 November 2013Researchers believe findings could help the many individuals for whom anti-depressants offer little or no relief
Imaging study shows dopamine dysfunction is not the main cause of Attention Deficit Hyperactivity Disorder (ADHD)
28 October 2013Research suggests that the main cause of the disorder may lie instead in structural differences in the grey matter in the brain.
Scientists identify depression and anxiety biomarker in youths
28 November 2012Test could be used as an inexpensive screening tool to facilitate early intervention.
̽»¨Ö±²¥ethics of smart drugs
31 October 2011Professor Barbara Sahakian, Professor of Clinical Neuropsychology at the ̽»¨Ö±²¥ of Cambridge, has been researching cognitive enhancers for over a decade. Here she discusses the emergence of ‘smart drugs’ and the ethical and practical issues they raise.
Study could help predict suicide in older adults
11 March 2010Focussing too much on the present and not using past experience to make decisions could be linked to suicide in elderly depressed adults, researchers from Cambridge and Pittsburgh have found.
